Cary O. Harding, MD, FACMG is Professor of Molecular and Medical Genetics and Pediatrics at Oregon Health & Science University (OHSU). He received his medical degree from the University of Washington followed by pediatric and medical genetics training at the University of Wisconsin-Madison. He is board certified in Clinical Genetics and Clinical Biochemical Genetics. Dr. Harding is a founding fellow of the American College of Medical Genetics and Genomics (ACMGG) and a member of the American Society for Cell and Gene Therapy (ASGCT) and Society for the Study of Inborn Errors of Metabolism (SSIEM). He is the treasurer of the Society for Inherited Metabolic Disorders (SIMD). He is an attending physician in the metabolic clinic at Doernbecher Children’s Hospital and the Medical Director of the Biochemical Genetics Lab at OHSU. He is also a clinical consultant to the Northwest Regional Newborn Screening Program. He serves as co-chair of the Scientific Advisory Board for the National PKU Alliance (NPKUA) and as the Project Director for the PHEFREE Rare Disorders Consortium. Dr. Harding’s basic and clinical research programs are focused upon the development of novel therapies, including gene and cell therapies, for inborn errors of metabolism.